Newswise — A new original research report available ahead-of-print at SLAS Technology demonstrates the semi-automation of a GlycoWorks RapiFluor-MS (RFMS) Kit using a pipetting robot to improve life sciences research productivity. This robotic platform uses standard manual pipettors and an optically guided arm to facilitate the automation of manual procedures, reducing the time researchers spend at the lab bench, and mimicking, as closely as possible, the results obtained when using the manual GlycoWorks RFMS protocol.

The GlycoWorks RapiFluor-MS (RFMS) Kit was launched in 2015 and simplifies the way researchers are able to release and tag N-linked glycans. The kit enables analysts to perform a high-yielding sample preparation and ensures precise and repeatable N-glycans profiles. The RFMS tag is unique in that it provides rapid tagging and supreme sensitivity for both optical and mass spectrometric analyses.

Authors Corey Reed, Jennifer Fournier and Stephan Koza of Waters Corporation (Milford MA) and Nikolas Vamvoukas of Andrew Alliance further simplify this sample preparation protocol through automation using a commercially available robotics solution from Andrew Alliance. Andrew, the pipetting robot, presents an ideal platform for automation of this kit with its ability to pipette low volumes and adapt to volume variability with customized dominos built specifically for this solution.

To accurately reproduce the results of the manual protocol, temperature sensitive steps are re-optimized for the automated platform and a range of temperatures are tested to achieve maximum N-glycan release efficiency. Following minor adjustments, the automated protocol proves to be statistically comparable to the manual protocol in terms of the recovery of RFMS labeled N-glycans as well as the resulting fluorescence relative peak areas. In addition, a sub-routine in the procedure simplifies the sample concentration normalization process prior to the RFMS protocol, saving users significant amounts of time.

In the end, the authors take a robust and easy to use protocol and successfully expand the benefits to life sciences research by increasing laboratory productivity. Users can now seamlessly transition from the manual protocol to the automated solution, relieving users from monotonous pipetting and controlling key areas of the protocol normally prone to user error.

* * * * *

Automated Preparation of MS-Sensitive Fluorescently Labeled N-Glycans with a Commercial Pipetting Robot can be accessed for free at http://journals.sagepub.com/doi/full/10.1177/2472630318762384. For more information about SLAS and its journals, visit www.slas.org/journals.

A PDF of this article is available to credentialed media outlets upon request. Contact [email protected].

About our Society and Journals

SLAS (Society for Laboratory Automation and Screening) is an international community of nearly 20,000 professionals and students dedicated to life sciences discovery and technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.

SLAS DISCOVERY: 2016 Impact Factor 2.444. Editor-in-Chief Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA). SLAS Discovery (Advancing Life Sciences R&D) was previously published (1996-2016) as the Journal of Biomolecular Screening (JBS).

SLAS TECHNOLOGY: 2016 Impact Factor 2.850. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore). SLAS Technology (Translating Life Sciences Innovation) was previously published (1996-2016) as the Journal of Laboratory Automation (JALA).

Follow SLAS on Twitter at @SLAS_Org.

Follow SLAS on Facebook at SocietyforLaboratoryAutomationandScreening.

Follow SLAS on YouTube at SLASvideo. 

Follow SLAS Americas on LinkedIn at Society for Laboratory Automation and Screening (SLAS Americas). 

Follow SLAS Europe on LinkedIn at Society for Laboratory Automation and Screening Europe (SLAS Europe).